ANDA 75342, held by Hospira. Butorphanol Tartrate.
As of Nov 16, 2026, ANDA 75342 (Butorphanol Tartrate), held by Hospira, was first approved by FDA on Nov 4, 1999, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 4, 1999 | Original application | Approved |
| Butorphanol Tartrate1MG/ML · injectable;injection | Butorphanol Tartrate | Discontinued |
| Butorphanol Tartrate2MG/ML · injectable;injection | Butorphanol Tartrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters